# Preclinical and Limited Clinical Evidence for Spirulina in Ulcerative Colitis: A Systematic Review and Meta-analysis

**Authors:** Khadije Gorgi, Zahra Ghanbarzadegan, Amir Darkhosh, Sara Shojaei-Zarghani, Seyed Vahid Hosseini

PMC · DOI: 10.34172/apb.025.46031 · Advanced Pharmaceutical Bulletin · 2025-08-18

## TL;DR

This study reviews preclinical and limited clinical evidence suggesting spirulina may help with ulcerative colitis, but more human trials are needed.

## Contribution

The novelty lies in systematically reviewing and meta-analyzing both animal and limited clinical evidence for spirulina in UC treatment.

## Key findings

- Spirulina improved body weight, colon length, and reduced oxidative stress in animal models of UC.
- Clinical features and inflammatory markers showed significant improvement in animal studies.
- No significant effect on disease activity was observed in the limited human RCT, but quality of life and stress scores improved.

## Abstract

Ulcerative colitis (UC) is a chronic inflammatory disease of the gastrointestinal tract. This study aimed to systematically review available animal and clinical studies on the effects of spirulina (Arthrospira platensis), a natural anti-inflammatory and antioxidant agent, on the condition of UC.

We conducted a systematic search in the PubMed, Scopus, Web of Science, and Embase databases for studies published from 1980 to April 2024. Experimental studies involving animal (mammalian) models or patients with UC were included. Pooled effect sizes were reported as mean differences (MD) or standardized mean differences (SMD) and 95% confidence intervals (CIs).

A total of 1,321 documents were identified through the systematic search. Following screening, 16 animal studies and 3 randomized controlled trials (RCTs), derived from one trial, were included. The beneficial effects of spirulina on body weight (MD=8.61, 95% CI=2.98 to 14.25, I2: 99.78%), clinical features (SMD=-2.39, 95% CI=-2.95 to -1.83, I2: 5.89%), colon length (MD=1.25, 95% CI=0.59 to 1.91, I2: 95.80%), oxidative stress, inflammatory markers, and gut microbiota in animal models of UC were reported. However, no effect of spirulina on disease activity was reported in the only RCT conducted. Nonetheless, improvements in quality of life, oxidative stress, sleep disturbances, stress scores, and anemia were noted.

Available animal studies suggest beneficial effects of spirulina on UC; however, the limited number of RCTs precludes definitive conclusions.

## Linked entities

- **Diseases:** ulcerative colitis (MONDO:0005101)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Diseases:** UC (MESH:D003093), inflammatory (MESH:D007249), anemia (MESH:D000740), sleep disturbances (MESH:D012893)
- **Species:** Spirulina (suborder) [taxon 551299], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12980208/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12980208/full.md

## References

46 references — full list in the complete paper: https://tomesphere.com/paper/PMC12980208/full.md

---
Source: https://tomesphere.com/paper/PMC12980208